Suggesting "maybe try this known inhibitor in other cell lines" isn't exactly novel information though. It'd be more impressive and useful if it hadn't had any published information about working as a cancer inhibitor before. People are blasé about it because it's not really beating the allegations that it's just a very fancy parrot when the highlight of it's achievements is to say try this known inhibitor with these other cell lines, decent odds that the future work sections of papers on the drug already suggested trying on other lines too...